Adverse events should be reported:

If, as a patient, you get any side effects talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed in the package leaflet.

By reporting side effects you can help provide more information on the safety of this medicine.

Reporting forms and information can be found at

Adverse events should also be reported to Grunenthal Ltd. at


Pain Treatments

Almost 20 per cent of the European population suffers from chronic pain, which is a major burden for both the persons concerned and their families.1

In order to relieve the pain, analgesic medications are typically used. The more severe the pain, the stronger the analgesic used, i.e. the further up the World Health Organisation (WHO) ladder. Grünenthal is specialised in pain therapy and is constantly searching for new ways to improve the quality of life of sufferers by providing effective and reliable analgesics. Grünenthal’s portfolio covers a variety of treatment options for both chronic and acute pain conditions. The products are available in more than 100 countries, most of them as prescription medicines.

In this section you will find information on our UK product portfolio:

1 Breivik H et al.: Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. European Journal of Pain, 2006; 10: 287-333

Contact for Medical Information, Reporting Safety and Quality Related Issues:

If you need more information about our products or wish to report an adverse event or product quality related issues, please contact us via the email address or our Medical Information department via the telephone number below:


Phone: + 44 870 351 8960
Fax: + 44 1494 486 298

M-ALL-UK-12-18-0003 Date of preparation December 2018

last update:  21 Jan 2019